BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 36316782)

  • 21. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
    Rosenstock P; Horstkorte R; Gnanapragassam VS; Harth J; Kielstein H
    Immunol Res; 2017 Oct; 65(5):1017-1024. PubMed ID: 28786023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The sialoglycan-Siglec-E checkpoint axis in dexamethasone-induced immune subversion in glioma-microglia transwell co-culture system.
    Wielgat P; Czarnomysy R; Trofimiuk E; Car H
    Immunol Res; 2019 Oct; 67(4-5):348-357. PubMed ID: 31741237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deacetylated sialic acids modulates immune mediated cytotoxicity via the sialic acid-Siglec pathway.
    Grabenstein S; Barnard KN; Anim M; Armoo A; Weichert WS; Bertozzi CR; Parrish CR; Willand-Charnley R
    Glycobiology; 2021 Nov; 31(10):1279-1294. PubMed ID: 34192335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer.
    Daly J; Carlsten M; O'Dwyer M
    Front Immunol; 2019; 10():1047. PubMed ID: 31143186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autologous tumor vaccines processed to express alpha-gal epitopes: a practical approach to immunotherapy in cancer.
    Galili U
    Cancer Immunol Immunother; 2004 Nov; 53(11):935-45. PubMed ID: 15205919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the Impact of Ketodeoxynonulosonic Acid in Host-Pathogen Interactions Using Uptake and Surface Display by Nontypeable Haemophilus influenzae.
    Saha S; Coady A; Sasmal A; Kawanishi K; Choudhury B; Yu H; Sorensen RU; Inostroza J; Schoenhofen IC; Chen X; Münster-Kühnel A; Sato C; Kitajima K; Ram S; Nizet V; Varki A
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative Analysis of Siglec Ligands by Flow Cytometry.
    Chang LY; Sridharan D; Angata T
    Curr Protoc; 2023 Dec; 3(12):e949. PubMed ID: 38050649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution and function of macrophage galactose-type C-type lectin 2 (MGL2/CD301b): efficient uptake and presentation of glycosylated antigens by dendritic cells.
    Denda-Nagai K; Aida S; Saba K; Suzuki K; Moriyama S; Oo-Puthinan S; Tsuiji M; Morikawa A; Kumamoto Y; Sugiura D; Kudo A; Akimoto Y; Kawakami H; Bovin NV; Irimura T
    J Biol Chem; 2010 Jun; 285(25):19193-204. PubMed ID: 20304916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells.
    Perdicchio M; Ilarregui JM; Verstege MI; Cornelissen LA; Schetters ST; Engels S; Ambrosini M; Kalay H; Veninga H; den Haan JM; van Berkel LA; Samsom JN; Crocker PR; Sparwasser T; Berod L; Garcia-Vallejo JJ; van Kooyk Y; Unger WW
    Proc Natl Acad Sci U S A; 2016 Mar; 113(12):3329-34. PubMed ID: 26941238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting sialic acid-Siglec interactions to reverse immune suppression in cancer.
    Adams OJ; Stanczak MA; von Gunten S; Läubli H
    Glycobiology; 2018 Sep; 28(9):640-647. PubMed ID: 29309569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elderberry bark lectins evolved to recognize Neu5Ac alpha2,6Gal/GalNAc sequence from a Gal/GalNAc binding lectin through the substitution of amino-acid residues critical for the binding to sialic acid.
    Kaku H; Kaneko H; Minamihara N; Iwata K; Jordan ET; Rojo MA; Minami-Ishii N; Minami E; Hisajima S; Shibuya N
    J Biochem; 2007 Sep; 142(3):393-401. PubMed ID: 17646175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting glycosylated antigens on cancer cells using siglec-7/9-based CAR T-cells.
    Meril S; Harush O; Reboh Y; Matikhina T; Barliya T; Cohen CJ
    Mol Carcinog; 2020 Jul; 59(7):713-723. PubMed ID: 32391973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing Efficacy of Enveloped Whole-Virus Vaccines by In situ Immune-Complexing with the Natural Anti-Gal Antibody.
    Galili U
    Med Res Arch; 2021 Jul; 9(7):. PubMed ID: 34853815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MUC1 Glycopeptide Vaccine Modified with a GalNAc Glycocluster Targets the Macrophage Galactose C-type Lectin on Dendritic Cells to Elicit an Improved Humoral Response.
    Gabba A; Attariya R; Behren S; Pett C; van der Horst JC; Yurugi H; Yu J; Urschbach M; Sabin J; Birrane G; Schmitt E; van Vliet SJ; Besenius P; Westerlind U; Murphy PV
    J Am Chem Soc; 2023 Jun; 145(24):13027-13037. PubMed ID: 37279388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments.
    Gianchecchi E; Arena A; Fierabracci A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The differences in significance of alpha 2,3Gal-linked and alpha 2,6GalNAc-linked sialic acid residues in blood group M- and N-related epitopes recognized by various monoclonal antibodies.
    Duk M; Sticher U; Brossmer R; Lisowska E
    Glycobiology; 1994 Apr; 4(2):175-81. PubMed ID: 7519909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Siglecs-7/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity.
    Ibarlucea-Benitez I; Weitzenfeld P; Smith P; Ravetch JV
    Proc Natl Acad Sci U S A; 2021 Jun; 118(26):. PubMed ID: 34155121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sialic acids as cellular markers of immunomodulatory action of dexamethasone on glioma cells of different immunogenicity.
    Wielgat P; Trofimiuk E; Czarnomysy R; Braszko JJ; Car H
    Mol Cell Biochem; 2019 May; 455(1-2):147-157. PubMed ID: 30443853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation.
    Spence S; Greene MK; Fay F; Hams E; Saunders SP; Hamid U; Fitzgerald M; Beck J; Bains BK; Smyth P; Themistou E; Small DM; Schmid D; O'Kane CM; Fitzgerald DC; Abdelghany SM; Johnston JA; Fallon PG; Burrows JF; McAuley DF; Kissenpfennig A; Scott CJ
    Sci Transl Med; 2015 Sep; 7(303):303ra140. PubMed ID: 26333936
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Yang J; Ma W; Wu Y; Zhou H; Song S; Cao Y; Wang C; Liu X; Ren J; Duan J; Pei Z; Jin C
    Microbiol Spectr; 2021 Dec; 9(3):e0039921. PubMed ID: 34878295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.